» Articles » PMID: 38512622

Image-based Artificial Intelligence for the Prediction of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer: a Systematic Review and Meta-analysis

Overview
Journal Radiol Med
Specialty Radiology
Date 2024 Mar 21
PMID 38512622
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Artificial intelligence (AI) holds enormous potential for noninvasively identifying patients with rectal cancer who could achieve pathological complete response (pCR) following neoadjuvant chemoradiotherapy (nCRT). We aimed to conduct a meta-analysis to summarize the diagnostic performance of image-based AI models for predicting pCR to nCRT in patients with rectal cancer.

Methods: This study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A literature search of PubMed, Embase, Cochrane Library, and Web of Science was performed from inception to July 29, 2023. Studies that developed or utilized AI models for predicting pCR to nCRT in rectal cancer from medical images were included. The Quality Assessment of Diagnostic Accuracy Studies-AI was used to appraise the methodological quality of the studies. The bivariate random-effects model was used to summarize the individual sensitivities, specificities, and areas-under-the-curve (AUCs). Subgroup and meta-regression analyses were conducted to identify potential sources of heterogeneity. Protocol for this study was registered with PROSPERO (CRD42022382374).

Results: Thirty-four studies (9933 patients) were identified. Pooled estimates of sensitivity, specificity, and AUC of AI models for pCR prediction were 82% (95% CI: 76-87%), 84% (95% CI: 79-88%), and 90% (95% CI: 87-92%), respectively. Higher specificity was seen for the Asian population, low risk of bias, and deep-learning, compared with the non-Asian population, high risk of bias, and radiomics (all P < 0.05). Single-center had a higher sensitivity than multi-center (P = 0.001). The retrospective design had lower sensitivity (P = 0.012) but higher specificity (P < 0.001) than the prospective design. MRI showed higher sensitivity (P = 0.001) but lower specificity (P = 0.044) than non-MRI. The sensitivity and specificity of internal validation were higher than those of external validation (both P = 0.005).

Conclusions: Image-based AI models exhibited favorable performance for predicting pCR to nCRT in rectal cancer. However, further clinical trials are warranted to verify the findings.

Citing Articles

Enhancing the role of MRI in rectal cancer: advances from staging to prognosis prediction.

Gong X, Ye Z, Shen Y, Song B Eur Radiol. 2025; .

PMID: 40045072 DOI: 10.1007/s00330-025-11463-x.


Predictive value of rectal MRI variables for pathological complete response in locally advanced rectal cancer following neoadjuvant chemoradiotherapy.

Li G, An Y, Zhang X, Wang C, Qiu X, Zhang G Int J Colorectal Dis. 2025; 40(1):42.

PMID: 39960557 PMC: 11832599. DOI: 10.1007/s00384-024-04801-w.

References
1.
Watanabe T, Muro K, Ajioka Y, Hashiguchi Y, Ito Y, Saito Y . Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int J Clin Oncol. 2017; 23(1):1-34. PMC: 5809573. DOI: 10.1007/s10147-017-1101-6. View

2.
Wan T, Zhang X, Liang C, Liao C, Li J, Zhou Y . The Prognostic Value of a Pathologic Complete Response After Neoadjuvant Therapy for Digestive Cancer: Systematic Review and Meta-Analysis of 21 Studies. Ann Surg Oncol. 2019; 26(5):1412-1420. DOI: 10.1245/s10434-018-07147-0. View

3.
Maas M, Nelemans P, Valentini V, Das P, Rodel C, Kuo L . Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. Lancet Oncol. 2010; 11(9):835-44. DOI: 10.1016/S1470-2045(10)70172-8. View

4.
Marijnen C . Organ preservation in rectal cancer: have all questions been answered?. Lancet Oncol. 2015; 16(1):e13-22. DOI: 10.1016/S1470-2045(14)70398-5. View

5.
Smith J, Paty P, Garcia-Aguilar J . Watch and Wait in Rectal Cancer or More Wait and See?. JAMA Surg. 2020; 155(7):657-658. PMC: 7483390. DOI: 10.1001/jamasurg.2020.0226. View